SEBBM - Sociedad Española de Bioquímica y Biología Molecular

Bienvenido | Welcome

Home  |   Contact  |   Site map

Facebook Twitter

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

Reference: Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4394-9 Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
Authors: Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, Ropero S, Kalluri R, Croce CM, Calin GA, Esteller M.
Summary: MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression at the posttranscriptional level and are critical for many cellular pathways. The disruption of miRNAs and their processing machineries also contributes to the development of human tumors. A common scenario for miRNA expression in carcinogenesis is emerging that shows that impaired miRNA production and/or down-regulation of these transcripts occurs in many neoplasms. Several of these lost miRNAs have tumor-suppressor features, so strategies to restore their expression globally in malignancies would be a welcome addition to the current therapeutic arsenal against cancer. Herein, we show that the small molecule enoxacin, a fluoroquinolone used as an antibacterial compound, enhances the production of miRNAs with tumor suppressor functions by binding to the miRNA biosynthesis protein TAR RNA-binding protein 2 (TRBP). The use of enoxacin in human cell cultures and xenografted, orthotopic, and metastatic mouse models reveals a TRBP-dependent and cancer-specific growth-inhibitory effect of the drug. These results highlight the key role of disrupted miRNA expression patterns in tumorigenesis, and suggest a unique strategy for restoring the distorted microRNAome of cancer cells to a more physiological setting.
Description:

 


Imágen artículo Mayo


REFERENCIA DEL GRUPO E INVESTIGADOR
El grupo del Dr Manel Esteller, Director del Programa de Epigenética y Biología del Cáncer (PEBC) del Instituto de Investigación Biomédica de Bellvitge (IDIBELL) e Investigador ICREA, está centrado en el estudio de los mecanismos epigenéticos implicados en patología humana, principalmente en el área del cancer. Sus trabajos han contribuido al conocimiento de los patrones alterados de metilación del DNA, modificación de histonas y producción de ARN no codificantes presentes en las células trasnformadas.

Descárgate este artículo aquí.
Más artículos en la revista SEBBM.

An error occurred while sending the vote.
You have already voted for this article.
An error occurred while saving the information. Try again.
You vote has been saved correctly.
Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. [+]
de Mayo

Sebastián D*, Hernández-Alvarez MI*, Segalés J*, Sorianello E, Muñoz JP, Sala D, Waget A,...
Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis.
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation [+]
de Abril

Josep M. Orellana-Gavaldà, Laura Herrero, Maria Ida Malandrino, Astrid Pañeda, María Sol...
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation
A novel GRK2/HDAC6 interaction modulates cell spreading and motility [+]
de Marzo

Vanesa Lafarga, Ivette Aymerich, Olga Tapia, Federico Mayor Jr, Petronila Penela
A novel GRK2/HDAC6 interaction modulates cell spreading and motility
Regulation of Ribonucleotide Reductase in Response to Iron Deficiency [+]
de Febrero

Nerea Sanvisens, Mari Carmen Bañó, Mingxia Huang y Sergi Puig
Regulation of Ribonucleotide Reductase in Response to Iron Deficiency

Did you publish an interesting article recently?

Send it through our application form and we will contact you.
Age limit: 32.
The selected articles will participate at the Fisher Scientific Prize which will be given during SEBBM conference, that will take place at Spain in 2012 (free registration, travel and accommodation).

SEBBM - Sociedad Española de Bioquímica y Biología Molecular
C/ Vitruvio 8, 28006, Madrid - SPAIN
Phone. +34 91 561 33 81 - Fax. +34 91 561 32 99
Contact | Legal warning - Foro - developed by Cadacual

¡CSS Válido! Icono de conformidad con el Nivel A, de las Directrices de Accesibilidad para el Contenido Web 1.0 del W3C-WAI Valid XHTML 1.0 Transitional

PROTECTOR MEMBERS